VPRIV ®,
TKT032
Phase 3 mab completed
Quick answer
VPRIV ®, for Gaucher Disease, Type 1 is a Phase 3 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 2 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Gaucher Disease, Type 1
- Phase
- Phase 3
- Modality
- mab
- Status
- completed